Linezolid Injection, Solution
Product Images NDC 0409-4883

This is a graph showing Linezolid plasma concentrations in pg/mL over time after administering 600mg orally every 12 hours. There are measurements taken up to 12 hours after the dose.*

This is a 300mL single-dose container of Linezolid Injection in 0.9% sodium chloride with a concentration of 600mg/300mL (2mg/mL) for intravenous infusion. Each mL contains Linezolid, citric acid anhydrous, sodium hydroxide, and sodium chloride. It is sterile and non-pyrogenic and must be stored at 20 to 25°C. It is a trademark of Hospira available by prescription only. If the text is for anything else other than this medication, it is not-available.*

Linezolid Injection in 0.9% Sodium Chloride is a single-dose container with 2mg and 1.82mg of Linszold and G Acid Anhydrous USP, respectively, that is used for intravenous infusion. It also contains Sodium Hydioside and Sodium Clorde USP in 076mg and 8mg quantities, respectively. The solution must be mixed with Sodium Hydroxide and/or Hydrochloric Acid. It should not be used in series connections, and the unused portion should be discarded. The dosage should be checked before use, and the overwrap should not be removed until ready for use. The overwrap is a moisture barrier; therefore, it must be visually inspected for tears or holes before use. If the overwrap is damaged, discard the unit. Visual inspection is also required post-removal of the overwrap to check for minute leaks. If any leaks are found, discard the solution because it may be ineffective. The product is temperature-sensitive and must be kept within 20-25°C (68-77°F) with excursions permitted from 16-30°C (59-86°F). The product is available in 300mL containers with NDC 0409-4883-11 and the code B wR1532.*